US Bancorp’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

US Bancorp’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-156	Closed	-$3K	–	3793
2017 Q4	$3K	Sell	156 -133	-46%	-$1.64K	﹤0.01%	3447
2017 Q3	$3K	Buy	289 +156	+117%	+$1.75K	﹤0.01%	3401
2017 Q2	$1K	Buy	+133	New	+$1.36K	﹤0.01%	3512

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

US Bancorp's SCMP Position: Q1 2018 in Review

US Bancorp sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 156 shares — an estimated $3K sold.

US Bancorp first reported a position in SCMP in Q2 2017 and held it in 3 quarters. The position peaked at $3K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

US Bancorp reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
US Bancorp sold 156 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $3K.
US Bancorp first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2017 and held it in 3 quarters.
US Bancorp's Sucampo Pharmaceuticals, Inc. position peaked at $3K in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on US Bancorp's 13F filing for Q1 2018, filed 8 May 2018.